WHOOP, the human performance company, has released groundbreaking research into the effects of GLP-1 therapies (eg. Ozempic), offering fresh insights into how these widely used weight-loss medications impact not only body weight but also heart health.
A study conducted by the WHOOP tracked data from 132 members undertaking GLP-1 therapies over a 12 week period to understand the impact these therapies have on our overall health.
Key Findings from the Study:
-
Meaningful Weight Loss: 90% of participants lost at least 5% of their body weight over the 12-week study, with an average weight loss of 10% per member logged. This surpassed typical results from traditional pharmaceutical trials.
-
Changes in Heart Health: GLP-1 therapies led to an increase in resting heart rate (RHR) by 3 beats per minute and a reduction in heart rate variability (HRV) by 6 milliseconds. These metrics in turn contribute to long-term cardiovascular health.
-
Increase in Physical Activity: Overall participants increased their weekly exercise by an average of 30 minutes. Interestingly, those who were more active experienced fewer negative health side effects (such as nausea, heartburn, and headaches), suggesting that physical activity plays a vital role in counteracting some of the physiological effects of GLP-1 medications.
This study is the first to demonstrate how 24/7 wearable technologies like WHOOP can support individuals using GLP-1 therapies by helping monitor and adjust physical activity levels for healthier outcomes. While GLP-1 medications can be transformative for weight management, the data collected by WHOOP suggests that combining therapy with regular exercise may help reduce potential cardiovascular side effects and preserve our heart health.
A spokesperson from WHOOP explains “At WHOOP, we empower our members to track how lifestyle choices and external factors impact their overall performance, providing a holistic approach to health and performance. Our Journal feature integrates GLP-1 tracking, offering members a clear view of how their medications, physical activity, and other habits interact, promoting smarter decisions for optimal results when it comes to your overall health. We’re excited to see how this research impacts overall behaviour and understanding of weight loss therapies moving forward.”
WHOOP continues to integrate lifestyle choice tracking into its unique platform, offering personalised insights that allow members to understand not just how their bodies perform, but why they experience changes. This enables members to make informed decisions to optimise their health and performance.
For more information about WHOOP technologies and their groundbreaking studies into human performance and optimisation, please visit www.whoop.com.
Follow our Journey with WHOOP